CFH-75635-67077
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 554 / MN
- Registered
- 2021-04-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-04
Registered in v-safe
-
2021-04-04
Dose 1 — Pfizer-BioNTech
- 2021-04-04
-
2021-04-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-20
-
2021-04-25
Dose 2 — Pfizer-BioNTech
- 2021-04-25
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-05-30
- 2021-06-06
- 2021-07-25
- 2021-10-24
-
2021-12-04
Dose 3 — Pfizer-BioNTech
-
2021-12-04
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Chills, Muscle or body achesAdult check-in
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, NauseaAdult check-in
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-18
-
2021-12-26
Survey response — day 21, dose 3MedDRA: Cough, Fatigue, Headache, Oropharyngeal pain, Pain, Rhinorrhoea, Sneezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fatigue, cough, sore throat, runny nose, headache, body aches, sneezingMedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Survey response — day 28, dose 3MedDRA: Hyposmia — Feeling: GoodFree text: Less sense of smellMedDRA releases: 2024-11 · check-in free text available
- 2022-01-08
- 2022-01-15
-
2022-03-05
Survey response — 3 months, dose 3MedDRA: Conjunctivitis, Cough, Respiratory tract congestion — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough, congestion, pink eyeMedDRA releases: 2024-11 · check-in free text available
-
2022-03-05
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-11
- 2022-06-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-04 | Pfizer-BioNTech | |
| 2 | 2021-04-25 | Pfizer-BioNTech | |
| 3 | 2021-12-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 21, dose 3
Symptoms: Fatigue, cough, sore throat, runny nose, headache, body aches, sneezing
Release 10 — day 28, dose 3
Symptoms: Less sense of smell
Release 11 — 3 months, dose 3
Symptoms: Cough, congestion, pink eye
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hyposmia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release